Dal‑led immunotherapy project awarded $3.2M from US-based National Cancer Institute

April 17, 2018

A Dalhousie Medical School cancer immunologist has received $3.2M in research support from the National Cancer Institute in the United States. Dal Assistant Professor in Pathology Shashi Gujar is working with University of North Carolina Professor Sherri McFarland to develop new immunotherapies for advanced melanoma. The project will specifically work to develop an immunotherapy treatment for advanced melanoma that would work similarly to a vaccine, a Dal release notes. “The success rate for this competition is often around 10 to 12 per cent,” says Gujar. “So of course, we are ecstatic.” Dal